AUSTIN, Texas, Dec. 3 /PRNewswire/ -- CN Group and Texas Healthcare & Bioscience Institute today announced the final agenda for the 4th annual Southwest Bio Venture Conference & Symposium in Houston, Texas on December 9 - 10, 2003. The two-day event will be held at the Hyatt Regency Downtown at 1200 Louisiana Street in the Imperial Ballroom. People wishing to attend the conference can call Alex Klingelberger at 512.314.0717 or register online at: http://www.cngroupllc.com/ . Press can attend Southwest Bio Venture Conference & Symposium free of charge by registering with Patti Hill, BlabberMouth PR, at 512.528.0201.
(All times are local.) Tuesday, December 9, 2003 7:00 AM Registration & Breakfast 8:00 AM Introduction / Welcome Remarks David Gerhardt, Managing Director, CN Group Tom Kowalski, President, Texas Healthcare & Bioscience Institute 8:15 AM Panel: Commercialization Moderator - Chris Kennerly, Baker Botts, LLP Arthur C. Vailas, Ph.D., Vice Chancellor/Vice President for Research and Intellectual Property, University of Houston David Gorenstein, Professor, UTMB William J. Doty, Managing Director of Technology Development, M.D. Anderson Cancer Center Dennis K. Stone, M.D., Vice President for Technology Development, UT Southwestern Medical Center 9:30 AM Keynote Address: UTMB’s Infectious Diseases Research Program: A Catalyst for Bioresearch in Texas John D. Stobo, M.D., President, University of Texas Medical Branch 10:30 AM Panel: Legal / Business Issues Moderator - Jaye Thompson, President, Synergos, Inc Margaret Sampson - Associate-Intellectual Property/Technical Litigation, Vinson & Elkins, LLC Christopher J. Ozburn - Wilson, Sonsini, Goodrich & Rosati PC Ray Sheeler, Director, CBiz Valuation Group Jennifer LeBlanc, Senior Manager, Pannell Kerr Forster of Texas, PC 12:00 PM Luncheon: Special Presentation “Venture Capitalists: Santa or Grinch?” Lisa A. Haile, J.D., Partner, Gray Cary Mark Wicker, Co-Chair, Gray Cary Life Sciences Group 1:30 PM Panel: Entrepreneur Perspective David Nance, President & CEO, Introgen Therapeutics 2:15 PM Panel: International Margaret Parton, TX-UK Programme Manager, Department of Trade & Industry, UK Ms. Chika Hashimoto, President, Gallasus Inc John M. Naples, Chief Financial Officer and Treasurer, Clinquest, Inc. 3:30 PM Three Panel Discussions - Grant Dollars, Strategic Partnering, & Equity Investors Grant Dollars Moderator - Scott Barnes, Assistant Vice President, Comerica Dr. Anna Barker, Deputy Director for Strategic Scientific Initiatives, National Cancer Institute Ted Roumel - Assistant Director of Technology Transfer, National Institutes of Health Strategic Partnering Moderator - Jacqueline Northcutt Waugh, President & CEO, BioHouston Greg Wiederrecht, Ph.D., Executive Director & Head, External Science Affairs, Merck Van Cosby - Channel Sales Manager - IBM Life Sciences Solutions Group Tom Amick, Vice President, Business Development, Johnson & Johnson Corporation Nick Manusos, Director of Licensing and Business Development, TAP Pharmaceuticals Equity Investors Moderator - David Gerhardt - Managing Director, CN Group Lloyd Bentsen, Managing Partner, Life Science CXO Fund Chris Kersey, Managing Director, Cogene BioTech Ventures William Paiva, Partner, Chisholm Private Capital Partners Steve Banks, Venture Partner, Techxas Ventures Stuart Lodge, Chief Financial Officer, Koch Ventures 5:30 PM Concluding Remarks 6:00 PM Kick-Off Reception Wednesday, December 10, 2003 7:00 AM Registration 8:00 AM Opening Remarks Newt Hamlin, Chairman & CEO, CN Group David Margrave, Chairman, THBI 8:30 AM Keynote Address G. Steven Burrill, CEO, Burrill & Company 9:00 AM Company Presentations Azopax (Boston / Austin) - Presentation by Steve Rowe PLx Pharma (Houston) - Presentation by Rom Zimmerman Lingual Care (Dallas) - Presentation by Lea Nesbit Organ Transport Systems (Dallas) - Presentation by Bob Kramer Amarillo Biosciences, Inc. (Amarillo) - Presentation by Joe Cummins Advocate MD (Austin) - Presentation by Mark Adams Opexa Pharmaceuticals (Houston) - Presentation by Michael Redman Kardia Therapeutics (Houston) - Presentation by William Altman 10:30 AM Break 11:00 AM Company Presentations Aronell Pharmaceuticals (Fort Worth) - Presentation by Nick Kerkhof C Sixty (Houston) - Presentation by Russ Lebovitz Spin Diagnostics (Houston) - Presentation by Shishir Shah VidaCare (San Antonio) - Presentation by Jim Thompsen Acclaim Biotechnology (Houston) - Presentation by John Chan Chrysilis Bio Technologies (Galveston) - Presentation by Dennis McWilliams MCRI (Austin) - Presentation by Bill Cooper 12:30 PM Bio Report - Resilience: Americas Biotechnology Report - 2003 Ernst & Young, Life Sciences 1:00 PM Lunch 2:00 PM Closing Dessert Reception About Capital Network Events
CN Events produces the nation’s leading Venture Capital and Private Equity and Angel Investor conference bringing together growth companies with investors. Through continued growth and thought leadership, CN Events has become the de facto standard for venture and private equity conferences. CN Events is one of three distinct, synergistic businesses held by CN Group, which provides a range of services to selected growth companies. The scope of services includes:
Merger and Acquisition Advisory Corporate Management Production of Premier Private Equity and Venture Capital Conferences Raising Capital Financial Advisory For more information please visit http://www.cngroupllc.com/ . About Texas Healthcare & Bioscience Institute
The Texas Healthcare & Bioscience Institute (THBI) is a public policy research organization, whose members consist of biotechnology, medical device, and pharmaceutical companies, academic and private research institutions, chambers of commerce, and local and regional economic development foundations.
The mission of THBI is to research, develop and advocate policies that promote life science innovation in Texas. For more information, visit http://www.thbi.com/ .
Media Contact: Patti D. Hill BlabberMouth Public Relations (512) 528 - 0201 patti@blabbermouthPR.com
CN Group; Texas Healthcare & Bioscience Institute
CONTACT: Patti D. Hill of BlabberMouth Public Relations,+1-512-528-0201, or patti@blabbermouthPR.com , for CN Group
